Target intelligence / Profile preview

Phosphatidylinositol-glycan biosynthesis class Z protein (PIGZ)

Target
PIGZ
Molecular classification
Enzyme, Glycosyltransferase (specifically, mannosyltransferase), Membrane protein, GPI-anchor biosynthesis enzyme
01

Overview

Phosphatidylinositol-glycan biosynthesis class Z protein (PIGZ) is an integral membrane glycosyltransferase involved in the stepwise assembly of the GPI anchor in the endoplasmic reticulum[3][6]. Specifically, it catalyzes the transfer of the fourth mannose residue (via an alpha-1,2 linkage) onto the GPI precursor, using dolichol-phosphate-mannose (Dol-P-Man) as the mannose donor[3][6]. The GPI anchor is an essential glycolipid modification that tethers a variety of proteins (GPI-anchored proteins) to the extracellular surface of the plasma membrane, playing key roles in cell signaling, adhesion, enzyme localization, and immune function[1][5][6]. PIGZ is part of a family of mannosyltransferases, sharing structural and mechanistic features with other enzymes in the GPI biosynthetic pathway[6]. Mutations affecting related steps in GPI-anchor biosynthesis are associated with rare congenital disorders of glycosylation that can have severe neurological and metabolic consequences[2].Direct information about drugs, mechanisms of action, or biomarker roles for PIGZ is not currently reported; its clinical significance centers on its enzymatic role in the biosynthetic pathway for GPI anchors and the resulting impact of its dysfunction on protein localization to the cell surface[2].

Other names
GPI alpha-1,2-mannosyltransferase 4GPI-MT-IVSMP3 homologGPI mannosyltransferase IVSMP3hSMP3FLJ12768MGC52163dol-P-Man dependent GPI mannosyltransferaseGPI mannosyltransferase 4SMP3 mannosyltransferasephosphatidylinositol-glycan biosynthesis class Z proteinSMP3 homolog (S. cerevisiae)
02

Biological functions

Glycosylphosphatidylinositol (GPI) anchor biosynthesisPost-translational protein modificationCell surface protein localizationProtein maturation and trafficking
03

Disease associations

Congenital disorders of glycosylation (subtype: GPI-anchor biosynthesis defects)Potential for involvement in neurological disorders and metabolic dysregulation related to GPI-anchor deficiency
04

Safety considerations

Disruption of GPI-anchor biosynthesis affects the maturation and surface localization of GPI-anchored proteins, which could lead to various clinical disorders, including neurological symptoms and alterations in enzyme presentation on the cell surface[2]

Beyond the preview

Go deeper on Phosphatidylinositol-glycan biosynthesis class Z protein (PIGZ).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Phosphatidylinositol-glycan biosynthesis class Z protein (PIGZ).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call